• Login
    View Item 
    •   DSpace Home
    • Akershus Universitetssykehus HF
    • AHUS - Medisinsk divisjon
    • View Item
    •   DSpace Home
    • Akershus Universitetssykehus HF
    • AHUS - Medisinsk divisjon
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    An update on cladribine for relapsing-remitting multiple sclerosis

    Thumbnail
    Abstract
    INTRODUCTION: Despite recent progress, currently available therapies for relapsing remitting multiple sclerosis (MS) are only partly effective, and their use is limited by tolerability and safety issues, as well as high cost. Cladribine was originally rejected by the regulatory authorities in both the European Union and USA in 2011, but in June 2017 the European Medical Agency recommended marketing authorization for treatment of aggressive relapsing MS. Areas covered: We provide an update on chemistry, mechanism of action, efficacy and safety of cladribine for the treatment of MS. Expert opinion: Cladribine is well tolerated, it is dosed orally in cycles of one year, the need for regular blood testing during treatment is likely limited, and the two-year efficacy data for treatment of relapsing MS are at least in the same range as the most efficient licensed treatments. The increased risk of malignancies reported in the pivotal trial seems to be caused by unexpectedly low numbers of malignancies in the placebo group. Cladribine could therefore be an alternative for many patients with relapsing remitting MS. The main caveat is the lack of long term efficacy and safety data. Currently there are insufficient data to guide further treatment of patients who have completed two treatment cycles of cladribine.
    URI
    https://hdl.handle.net/10642/7264
    Collections
    • AHUS - Medisinsk divisjon
    Date
    2017-09-11
    Author
    Holmøy, Trygve
    Torkildsen, Øivind Fredvik
    Myhr, Kjell-Morten
    Show full item record
    Holmøy - An update on cladribine for relapsing-remitting multiple sclerosis.pdf (359.4Kb)

    copyright © 2017 Oslo and Akershus University College of Applied Sciences
    Contact Us | Send Feedback
    Powered by KnowledgeArc
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    copyright © 2017 Oslo and Akershus University College of Applied Sciences
    Contact Us | Send Feedback
    Powered by KnowledgeArc